newsfilter
← Latest News
Business Wire·

Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio

Focuses Company's resources on its deep clinical oncology pipeline Positioned to advance four clinical programs through multiple upcoming milestones Repare Therapeutics Inc. ("Repare" or the "Company")